CN103360448A - 美他卡韦乙醇溶剂化合物的单晶晶型,及制备方法 - Google Patents
美他卡韦乙醇溶剂化合物的单晶晶型,及制备方法 Download PDFInfo
- Publication number
- CN103360448A CN103360448A CN2012101001290A CN201210100129A CN103360448A CN 103360448 A CN103360448 A CN 103360448A CN 2012101001290 A CN2012101001290 A CN 2012101001290A CN 201210100129 A CN201210100129 A CN 201210100129A CN 103360448 A CN103360448 A CN 103360448A
- Authority
- CN
- China
- Prior art keywords
- crystal formation
- solvent compound
- preparation
- mei
- alcohol solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101001290A CN103360448A (zh) | 2012-04-09 | 2012-04-09 | 美他卡韦乙醇溶剂化合物的单晶晶型,及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101001290A CN103360448A (zh) | 2012-04-09 | 2012-04-09 | 美他卡韦乙醇溶剂化合物的单晶晶型,及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103360448A true CN103360448A (zh) | 2013-10-23 |
Family
ID=49362784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101001290A Pending CN103360448A (zh) | 2012-04-09 | 2012-04-09 | 美他卡韦乙醇溶剂化合物的单晶晶型,及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103360448A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101220071A (zh) * | 2008-01-17 | 2008-07-16 | 南京长澳医药科技有限公司 | 稳定的6-甲氧基-2’,3’-双脱氧鸟嘌呤核苷及其制备方法和包含它的药物组合物 |
CN102070691A (zh) * | 2010-12-22 | 2011-05-25 | 南京长澳医药科技有限公司 | 一种美他卡韦晶型,其制备方法以及包含它的药物组合物 |
US20110150836A1 (en) * | 2009-12-22 | 2011-06-23 | Gilead Sciences, Inc. | Methods of treating hbv and hcv infection |
-
2012
- 2012-04-09 CN CN2012101001290A patent/CN103360448A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101220071A (zh) * | 2008-01-17 | 2008-07-16 | 南京长澳医药科技有限公司 | 稳定的6-甲氧基-2’,3’-双脱氧鸟嘌呤核苷及其制备方法和包含它的药物组合物 |
US20110150836A1 (en) * | 2009-12-22 | 2011-06-23 | Gilead Sciences, Inc. | Methods of treating hbv and hcv infection |
CN102070691A (zh) * | 2010-12-22 | 2011-05-25 | 南京长澳医药科技有限公司 | 一种美他卡韦晶型,其制备方法以及包含它的药物组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105646584B (zh) | 替诺福韦艾拉酚胺富马酸盐晶型及其制备方法和用途 | |
CN105859709A (zh) | 二氢嘧啶衍生物的复合物及其在药物中的应用 | |
WO2009026790A1 (en) | Crystal entecavir fomulation and the preparation method thereof | |
CN104000789A (zh) | 一种阿德福韦酯分散片及其制备方法 | |
CN101671337B (zh) | 枸橼酸爱地那非晶型a及其制备方法和用途 | |
CN115154433A (zh) | 一种富马酸替诺福韦二吡呋酯片剂及其制备方法 | |
CN1872853A (zh) | 嘌呤衍生物 | |
US20050272687A1 (en) | Stable S-adenosyl-l-methionine | |
CN101220071B (zh) | 稳定的6-甲氧基-2’,3’-双脱氧鸟嘌呤核苷及其制备方法和包含它的药物组合物 | |
CN102070691B (zh) | 一种美他卡韦晶型,其制备方法以及包含它的药物组合物 | |
JP2007515495A (ja) | 4’−置換カルボビル誘導体およびアバカビル誘導体ならびにhivおよびhcv抗ウイルス活性を有する関連化合物 | |
CN103360448A (zh) | 美他卡韦乙醇溶剂化合物的单晶晶型,及制备方法 | |
AU2015292050B2 (en) | New polycrystalline form of tenofovir prodrug, and preparation method and application therefor | |
CN103159815B (zh) | 单磷酸阿糖腺苷结晶化合物、药物组合物及其制备方法 | |
CN103054817B (zh) | 一种单磷酸阿糖腺苷的药物组合物及其制备方法 | |
CA2044125A1 (en) | Anti-hbv pyrimidine nucleoside | |
CN103127028A (zh) | 一种含有富马酸替诺福韦二吡呋酯的胶囊剂 | |
CN101953773B (zh) | 一种拉米夫定脂质体固体制剂 | |
JPH07502741A (ja) | 治療用ヌクレオシド | |
CN102485229B (zh) | 抗病毒药物 | |
CN101732316A (zh) | 拉米夫定制剂及其制备方法 | |
CN107849074A (zh) | 一种核苷类似物的烷氧烷基酯前药及其应用 | |
CN108553437A (zh) | 一种通过离子交换技术制得的巯嘌呤咀嚼片及其制备方法 | |
CN115429812B (zh) | 一种Molnupiravir磷脂复合物及其制备方法 | |
CN103933037B (zh) | 一种含有脱氢卡维丁的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU VANKING PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: CHANG'AO SCIENCE AND TECHNOLOGY OF MEDICAL INDUSTRY CO LTD, NANJING Effective date: 20141021 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210038 NANJING, JIANGSU PROVINCE TO: 510760 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141021 Address after: 510760 Guangdong city of Guangzhou province Guangzhou economic and Technological Development Zone East Road No. 6 self building Applicant after: Guangzhou Yipinhong Pharmaceutical Co.,Ltd. Address before: 210038 Nanjing economic and Technological Development Zone, Jiangsu Province, No. Wing Road, No. 1 Applicant before: Chang'ao Science and Technology of Medical Industry Co., Ltd., Nanjing |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Hanxiong Inventor after: Liu Cailian Inventor after: Yang Xiaobing Inventor after: Xu Chao Inventor after: Wang Zhengze Inventor after: Chu Gang Inventor after: Huang Haiyan Inventor after: Li Wei Inventor before: Liu Cailian Inventor before: Yang Xiaobing Inventor before: Xu Chao Inventor before: Wang Zhengze Inventor before: Chu Gang Inventor before: Huang Haiyan Inventor before: Li Wei |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20131023 |
|
RJ01 | Rejection of invention patent application after publication |